Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients

Clinical trial NCT02421120 · COMPLETED

Trial details

NCT number: NCT02421120
Sponsor: Joseph L. Kuti, PharmD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis Cystic Fibrosis Pulmonary Exacerbation Pseudomonas Aeruginosa Infection

Start date: 2015-09-01
Primary completion: 2016-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.